Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The multidrug resistance pathway encompasses diverse molecular strategies enabling cells—especially tumor cells—to evade the effects of multiple therapeutic agents through mechanisms such as increased drug efflux via ABC transporters like P‑glycoprotein/MDR1. This remains a critical target for research into overcoming treatment failures in both oncology and infectious disease settings.
Multiple mechanisms including drug efflux, drug inactivation, target modification, and enhanced DNA repair.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multidrug Resistance Pathway.